1. A dance game system comprising:
a host comprising:
a data inputting interface communicating with a storage medium storing at least one audio signal and at least one prompting signal;
an audio outputting unit outputting the audio signal;
a prompting unit prompting step directions of a user;
a control unit electrically coupled to the data inputting interface, the audio outputting unit, and the prompting unit, receiving the audio signal and transmitting the audio signal to the audio outputting unit, and receiving the prompting signal and controlling the prompting unit according to the prompting signal;
a first transceiver receiving a step signal, wherein the control unit determines whether or not a step of the user is correct according to the step signal;
a user interface, whereby the user operates the host; and
a power supply unit providing power to the host; and
a motion sensor worn on feet of the user and comprising:
an acceleration sensor sensing the step of the user and outputting a sensation signal;
a processing unit electrically coupled to the acceleration sensor, processing the sensation signal, and outputting the step signal;
an second transceiver electrically coupled to the processing unit and transmitting the step signal; and
a battery module providing power to the motion sensor.
2. The dance game system according to claim 1 further comprising a communication port electrically coupled to the processing unit, whereby the host exchanges data with another host.
3. The dance game system according to claim 2, wherein the communication port includes a wired communication port or a wireless communication port.
4. The dance game system according to claim 1, wherein the prompting unit comprises a plurality of light emitting diodes.
5. The dance game system according to claim 4, wherein the light emitting diodes are respectively arranged in 4-8 directions.
6. The dance game system according to claim 1, wherein the audio outputting unit includes a built-in speaker.
7. The dance game system according to claim 1, wherein the audio outputting unit includes an external speaker.
8. The dance game system according to claim 1, wherein the user interface comprises a plurality of buttons and a built-in display unit.
9. The dance game system according to claim 1, wherein the storage medium is a memory card or a game cartridge.
10. The dance game system according to claim 1, wherein the audio signal is a music signal, a voice signal, a sound effect signal, or a combination thereof.
11. The dance game system according to claim 1, wherein the acceleration sensor is a two-axial acceleration sensor or a three-axis acceleration sensor.
12. The dance game system according to claim 1, wherein a communication frequency of the first transceiver and the second transceiver is an ISM band (Industrial Scientific Medical band).
13. The dance game system according to claim 1, wherein each of the first transceiver and the second transceiver includes a Bluetooth module or a WLAN (wireless local area network) module.
14. The dance game system according to claim 1, wherein the power supply unit includes rechargeable battery, a disposable battery or an external power source.
15. The dance game system according to claim 1, wherein the battery module includes rechargeable battery or a disposable battery.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. A method of identifying a virus strain in a sample comprising:
a) contacting nucleic acid from the sample with at least one pair of oligonucleotide primers which hybridize to sequences of the nucleic acid, wherein the sequences flank a variable acid sequence of the virus strain;
b) amplifying the variable nucleic acid sequence to produce an amplification product;
c) determining the molecular mass or base composition of the amplification product; and
d) identifying the virus strain.
2. The method of claim 1 wherein step d) comprises comparing the molecular mass or base composition of the amplification product to one or more molecular masses or base compositions of amplification products obtained by performing steps a) through c) on a plurality of known virus strains, wherein a match identifies the virus strain.
3. The method of claim 1 wherein the sequences to which the at least one pair of oligonucleotide primers hybridize are highly conserved.
4. The method of claim 1 wherein the amplifying step comprises polymerase chain reaction.
5. The method of claim 1 wherein the amplifying step comprises ligase chain reaction or strand displacement amplification.
6. The method of claim 1 wherein the virus strain is an arenavirus, bunyavirus, monoegaviras, picornavirus, astrovirus, calcivirus, nidovirus, flavivirus, togavirus, or retrovirus.
7. The method of claim 1 wherein the virus strain is a sabia virus, lassa vever virus, Machupo Virus, Argentine hemorrhagic fever virus, flexal virus, hantavirus, nairovirus, phlebovirus, Hantaan virus, Congo-crimean hemorrhagic fever virus, Rift valley fever virus, filovirus, paramyxovirus, ebola virus, Marburg virus, Equine morbillivirus, coxsackievirus, echovirus, human coxsackievirus A, human echovirus, human enterovirus, human poliovirus, hepatitis A virus, human parechovirus, human rhinovirus, human astrovirus, chiva virus, chitta virus, human calcivirus, norwalk virus, human coronavirus, human torovirus, Alfuy virus, Alkhurma virus, Apoi virus, Aroa virus, Bagaza virus, Banzi virus, Batu cave virus, Bouboui virus, Bukalasa bat virus, Bussliquara virus, Cacipacore virus, Carey island virus, Cowbone ridge virus, Dakar bat virus, Deer tick virus, Dengue virus type 1, Dengue virus type 2, Dengue virus type 3, Dengue virus type 4, Edge hill virus, Entebbe bat virus, Flavivirus sp., Gadgets gully virus, Hepatitis C virus, Iguape virus, Ilheus virus, Israel turkey meningoencephalitis virus, Japanese encephalities virus, Jugra virus, Jutiapa virus, Kadam virus, Kedougou virus, Kokobera virus, Koutango virus, Kunjin virus, Kyasanur forest disease virus, Langat aviurs, Louping III virus, Maeban virus, Modoc virus, Montana myotic leukoencephalitis virus, Murray Valley encephalitis virus, Naranjal virus, Negishi virus, Ntaya virus, Omsk hemorrhagic fever virus, Phnom-Penh bat virus, Potiskum virus, Powassan virus, Rio bravo virus, Rocio virus, Royal farm virus, Russian spring-summer encephalitis virus, Saboya virus, Saint Louis encephalitis virus, Sal vieja virus, San perlita virus, Saumarez reef virus, Sepik virus, Sitiawan virus, Sokuluk virus, Spondweni virus, Stratford virus, Tembusu virus, Tick-borne encephalitis virus, Tyulenly virus, Uganda 5 virus, Usutu virus, West Nile virus, Yellow fever virus, Chikugunya virus, Eastern equine encephalitis virus, Mayaro virus, O’nyong-nyong virus, Ross river virus, Venezuelan equine encephalitis virus, Rubella virus, hepatities E virus, human immuodefeciency virus, or hepatitis B virus.
8. The method of claim 1 wherein the nucleic acid is ribosomal RNA.
9. The method of claim 1 wherein the nucleic acid encodes RNase P or an RNA-dependent RNA polymerase.
10. The method of claim 1 wherein the amplification product is ionized prior to molecular mass or base composition determination.
11. The method of claim 1 further comprising the step of isolating nucleic acid from the virus prior to contacting the nucleic acid with the at least one pair of oligonucleotide primers.
12. The method of claim 1 further comprising the step of performing steps a) through d) using a different oligonucleotide primer pair and comparing the results to molecular mass or base composition of one or more amplification products obtained by performing steps a) through c) on a different plurality of known viruses from those in step d).
13. The method of claim 1 wherein the one or more molecular masses or base compositions are contained in a database of molecular masses or base compositions.
14. The method of claim 1 wherein the amplification product is ionized by electrospray ionization, matrix-assisted laser desorption or fast atom bombardment.
15. The method of claim 1 wherein the molecular mass or base composition is determined by mass spectrometry.
16. The method of claim 15 wherein the mass spectrometry is Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS), ion trap, quadrupole, magnetic sector, time of flight (TOF), Q-TOF, or triple quadrupole.
17. The method of claim 1 further comprising performing step b) in the presence of an analog of adenine, thymidine, guanosine or cytidine having a different molecular weight than adenosine, thymidine, guanosine or cytidine.
18. The method of claim 1 wherein the oligonucleotide primer comprises a base analog at positions 1 and 2 of each triplet within the primer, wherein the base analog binds with increased affinity to its complement compared to the native base.
19. The method of claim 18 wherein the primer comprises a universal base at position 3 of each triplet within the primer.
20. The method of claim 18 wherein the base analog is a 2,6-diaminopurine, propyne T, propyne G, phenoxazine, or G-clamp.
21. The method of claim 19 wherein the universal base is an inosine, guanidine uridine, 5-nitroindole, 3-nitropyrrole, dP, dK, or 1-(2-deoxy–D-ribofuranosyl)-imidazole-4-carboxamide.
22. A method of distinguishing a first virus strain in a sample from at least a second virus strain comprising:
a) contacting nucleic acid from the first virus strain in the sample with at least one pair of oligonucleotide primers which hybridize to sequences of the nucleic acid, wherein the sequences flank a variable acid sequence of the first virus strain;
b) amplifying the variable nucleic acid sequence to produce an amplification product;
c) determining the molecular mass or base composition of the amplification product; and
d) distinguishing the first virus strain.
23. The method of claim 22 wherein step d) comprises comparing the molecular mass or base composition of the amplification product to the molecular mass or base composition of an amplification product from the at least second virus strain obtained by performing steps a) through c) on the at least second virus strain, wherein a different molecular mass for the amplification product of the first virus strain compared to the molecular mass of the at least second virus strain distinguishes the first virus strain.
24. The method of claim 22 wherein the virus strain is a hepatitis virus, a human rhinovirus, an encephalitis virus, or a human immuodefeciency virus.